OPKO Health Inc.
An integrated healthcare company in pharmaceuticals and diagnostic laboratory services.
OPK | TA
Overview
Corporate Details
- ISIN(s):
- US68375N1037
- LEI:
- Country:
- Israel
- Address:
- 4400 Biscayne Blvd., 33137 Miami
- Website:
- https://www.opko.com
- Industry:
- Other human health activities
Description
OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-10-13 22:16 |
OPKO Health to Report Third Quarter 2020 Financial Results and conference call …
|
English | 36.0 KB | ||
| 2020-10-09 21:40 |
OPKO Launches COVID-19 Testing Program for New York City Schools
|
English | 171.1 KB | ||
| 2020-10-09 21:40 |
OPKO Launches COVID-19 Testing Program for New York City Schools
|
English | 36.1 KB | ||
| 2020-10-08 20:57 |
Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Lon…
|
English | 205.1 KB | ||
| 2020-10-08 20:57 |
Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Lon…
|
English | 36.2 KB | ||
| 2020-09-15 23:16 |
Presentation, September 2020
|
English | 2.2 MB | ||
| 2020-09-15 23:16 |
Presentation, September 2020
|
English | 36.0 KB | ||
| 2020-09-15 23:12 |
attended the H.C. Wainwright 22nd Annual Global Investment Virtual Conference a…
|
English | 84.7 KB | ||
| 2020-09-15 23:12 |
attended the H.C. Wainwright 22nd Annual Global Investment Virtual Conference a…
|
English | 36.0 KB | ||
| 2020-09-15 20:40 |
Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
|
English | 221.2 KB | ||
| 2020-09-15 20:40 |
Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
|
English | 35.9 KB | ||
| 2020-09-03 03:16 |
Participate in Two September Investment Conferences
|
English | 144.1 KB | ||
| 2020-09-03 03:16 |
Participate in Two September Investment Conferences
|
English | 35.9 KB | ||
| 2020-09-02 20:27 |
OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-1…
|
English | 172.7 KB | ||
| 2020-09-02 20:27 |
OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-1…
|
English | 36.0 KB |
Automate Your Workflow. Get a real-time feed of all OPKO Health Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OPKO Health Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OPKO Health Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
